Top Gainers for 5-22-23: $CNSP $FRLN $HEPA $MBOT $NCPL

$CNSP - CNS Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update: https://finance.yahoo.com/news/cns-pharmaceuticals-reports-first-quarter-123500631.html

$FRLN - Freeline Granted ILAP Designation in United Kingdom by MHRA for FLT201, an Investigational Gene Therapy for the Treatment of Gaucher Disease: https://finance.yahoo.com/news/freeline-granted-ilap-designation-united-120000796.html

$HEPA - Hepion Pharmaceuticals’ Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and Multiple NASH Biomarkers: https://finance.yahoo.com/news/hepion-pharmaceuticals-phase-2-altitude-110000500.html

$MBOT - Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules: https://finance.yahoo.com/news/microbot-medical-announces-1-4-191800116.html

$NCPL - Sidoti's Micro-Cap Virtual May Conference: https://finance.yahoo.com/news/sidotis-micro-cap-virtual-may-111500347.html